|
|
| APB-101 / Apic Bio (0 Trials) |
|
| APB-104 / Apic Bio (0 Trials) |
|
| APB-105 / Apic Bio (0 Trials) |
|
| APB-A2 / AprilBio (0 Trials) |
|
| APB-BS2 / AprilBio (0 Trials) |
|
| APB-R4 / AprilBio (0 Trials) |
|
| APC-100 / DMK Pharma (1 Trials) |
|
| APCEDEN-CR (autologous dendritic cell immunotherapy) / APAC Biotech (0 Trials) |
|
| APCEDEN-O (autologous dendritic cell immunotherapy) / APAC Biotech (0 Trials) |
|
| APCEDEN-P (autologous dendritic cell immunotherapy) / APAC Biotech (0 Trials) |
|
| Apceth regeneration and disease modulation program / Minaris Regenerative Medicine (0 Trials) |
|
| apceth-301 / Minaris Regenerative Medicine (0 Trials) |
|
| APD-209 / Adenovir (0 Trials) |
|
| APD418 / Pfizer (0 Trials) |
|
| APD597 / Pfizer (0 Trials) |
|
| Apeaz (camphor/menthol/methyl salicylate) / Aytu BioPharma (0 Trials) |
|
| APG 101.10 / Allostera (0 Trials) |
|
| APG 201 / Apogenix, German Cancer Research Center (0 Trials) |
|
| APG-1387 / Ascentage Pharma (0 Trials) |
|
| APG-157 / Aveta Biomics (0 Trials) |
|
| APG-1842 / Ascentage Pharma (0 Trials) |
|
| APG-2449 / Ascentage Pharma (0 Trials) |
|
| APG-265 / Ascentage Pharma (0 Trials) |
|
| APG-3526 / Ascentage Pharma (0 Trials) |
|
| APG-5918 / Ascentage Pharma (0 Trials) |
|
| APG1244 / Ascentage Pharma (0 Trials) |
|
| APG350 / Apogenix, AbbVie (0 Trials) |
|
| APH-0703 / Aphios, Louisiana State University (0 Trials) |
|
| APH-0812 / Aphios (0 Trials) |
|
| APH-0912 / Aphios (0 Trials) |
|
| APH-1104 / Aphios (0 Trials) |
|
| APH-1104 analog / Aphios (0 Trials) |
|
| APH-1104 less potent analog / Aphios (0 Trials) |
|
| APH1105 / Aphios (0 Trials) |
|
| Aphexda (motixafortide) / BioLineRx, Ayrmid (8 Trials) |
|
| Aphthasol (amlexanox) / Abeona Therap, Esteve (0 Trials) |
|
| Apidra (insulin glulisine) / Sanofi (10 Trials) |
|
| apilimod (STA-5326) / Madrigal Pharma (0 Trials) |
|
| apilimod dimesylate (AIT-101) / OrphAI Therap (1 Trials) |
|
| apimostinel IV (GATE-202) / Gate Neurosciences (0 Trials) |
|
| apimostinel oral (AGN-241660 oral) / AbbVie (0 Trials) |
|
| apitegromab (SRK-015) / Scholar Rock (0 Trials) |
|
| apitolisib (GDC-0980) / Roche (0 Trials) |
|
| Apitox (honeybee venom) / Apimeds (1 Trials) |
|
| apixaban / Generic mfg. (116 Trials) |
|
| APJ agonist / BMS (0 Trials) |
|
| APL-1 / Apellis (0 Trials) |
|
| APL-102 / Apollomics (0 Trials) |
|
| APL-103 / Apollomics (0 Trials) |
|
| APL-122 / Apollomics (0 Trials) |
|
| APL-1501 / Asieris (0 Trials) |
|
| APL-1901 / Asieris (0 Trials) |
|
| APL-509 / JSR Life Sciences, Jiangsu Qyun Bio-Pharma, Apollomics (0 Trials) |
|
| APL-581 / Aptose Biosci, Ohm Oncology (0 Trials) |
|
| APL-601 / Apollomics (0 Trials) |
|
| APL-801 / Apollomics (0 Trials) |
|
| APL-810 / TYG Oncology, OncoQR, Apollomics (0 Trials) |
|
| APL-9 / Apellis (0 Trials) |
|
| APL180 / Novartis (0 Trials) |
|
| Aplenzin (bupropion hydrobromide ER) / Bausch Health (3 Trials) |
|
| Apleway (tofogliflozin) / Kowa, Takeda (2 Trials) |
|
| Aplidin (plitidepsin) / PharmaMar, Roche (7 Trials) |
|
| aplindore (SLS-006) / Seelos Therap (0 Trials) |
|
| aplitabart (IGM-8444) / IGM Biosciences (0 Trials) |
|
| APN-122597 / Atreca (0 Trials) |
|
| APN-346958 / Atreca, Xencor (0 Trials) |
|
| APN-497444 / Atreca (0 Trials) |
|
| APN-541885 / Atreca (0 Trials) |
|
| APN-959038 / Atreca (0 Trials) |
|
| APN1125 / CoMentis, Alpharmagen (0 Trials) |
|
| APN431 / Apeiron Biologics (0 Trials) |
|
| APNmAb005 / APRINOIA Therap (0 Trials) |
|
| APO-EPO (epoetin alfa biosimilar) / Apotex (1 Trials) |
|
| APO-go (apomorphine continuous subcutaneous infusion) / Stada, Kyowa Kirin, Endo, Supernus Pharma (5 Trials) |
|
| Apo805K1 / Apotex (0 Trials) |
|
| apoA-I (CSL112) / CSL Behring (1 Trials) |
|
| ApoB SNALP (PRO-040201) / Arbutus (0 Trials) |
|
| Apocept (asunercept) / Apogenix (2 Trials) |
|
| apocynin/paeonol (AKL-4) / AKL Research and Development (0 Trials) |
|
| Apofin (apomorphine) / Chiesi (1 Trials) |
|
| apogossypol (CNDO103) / Fortress (0 Trials) |
|
| ApoGraft (allogeneic mobilised peripheral blood cells) / Cellect Biotechnology (2 Trials) |
|
| Apograft-treated stem cells / Cellect Biotechnology (0 Trials) |
|
| ApoGuard (desmethylselegiline) / RetinaPharma (0 Trials) |
|
| Apokyn (apomorphine bolus injection) / Stada, Supernus Pharma, Aguettant (5 Trials) |
|
| Apolactoferrin (talactoferrin alfa) / Agennix (0 Trials) |
|
| apomorphine (apomorphine Linguet) / Imugene (0 Trials) |
|
| apomorphine inhalational (AZ-009) / Ferrer International (0 Trials) |
|
| apomorphine inhalational (VR 040) / Vectura, Kyowa Kirin (1 Trials) |
|
| apomorphine intranasal / Kyowa Kirin, Stada (0 Trials) |
|
| apomorphine intranasal (AL-101) / Oncotelic (0 Trials) |
|
| apomorphine pump (SHX-018) / Guangzhou Dazhou Biomedicine (0 Trials) |
|
| apomorphine SC (ND0701) / Mitsubishi Tanabe (0 Trials) |
|
| apomorphine sublingual spray / Renown Pharma (0 Trials) |
|
| apomorphine sustained release (ALA-4000) / Alar Pharma (0 Trials) |
|
| apomorphine transdermal / Nutriband (0 Trials) |
|
| apomorphine transdermal patch (PassPort Apomorphine HCL Patch) / Nitto Denko, Teikoku (0 Trials) |
|
| Apoptone (HE 3235) / Harbor Biosci (0 Trials) |
|
| apoptotic Factor (rh-Apo2l) / Aida Pharma (0 Trials) |
|
| Apovir (pleconaril/ribavirin) / Apodemus (3 Trials) |
|
| APP-0205 / Aphios (0 Trials) |
|
| APP-069 / Aphios (0 Trials) |
|
| APP-309 / Aphios (0 Trials) |
|
| APP-401 / Aphios (0 Trials) |
|
| App2-M1 / ContraFect (0 Trials) |
|
| Appetite modulator / Boehringer Ingelheim (0 Trials) |
|
| APPL-001 / Celularity (0 Trials) |
|
| APR-1051 / Aprea (0 Trials) |
|
| APR-548 / Aprea (0 Trials) |
|
| APR002 / Apros Therap (0 Trials) |
|
| APR003 / Apros Therap (0 Trials) |
|
| apraclonidine / Generic mfg. (1 Trials) |
|
| apraglutide (FE 203799) / Ironwood Pharma (4 Trials) |
|
| apramycin (EBL-1003) / Juvabis (0 Trials) |
|
| apremilast / Generic mfg. (41 Trials) |
|
| aprepitant gel / LEO Pharma (0 Trials) |
|
| aprepitant oral / Generic mfg. (15 Trials) |
|
| aprepitant topical (HT-001) / Hoth Therap (0 Trials) |
|
| Apretude (cabotegravir extended-release injectable suspension) / ViiV Healthcare (0 Trials) |
|
| apricitabine (AVX754) / TBG Diagnostics (1 Trials) |
|
| Apristor (onapristone XR) / Context Therap (2 Trials) |
|
| aprotinin / Generic mfg. (11 Trials) |
|
| aprotinin (EG-1964) / PDS Biotech (0 Trials) |
|
| Aprovasc (amlodipine/irbesartan) / Sanofi, Sumitomo Pharma, Shionogi (3 Trials) |
|
| aprutumab (BAY 1179470) / Bayer (0 Trials) |
|
| aprutumab ixadotin (BAY1187982) / Bayer (0 Trials) |
|
| APS03118 / Applied Pharmaceutical Sci (0 Trials) |
|
| APS08 / Applied Pharmaceutical Sci (0 Trials) |
|
| APS3010 / Sunshine Biopharma (0 Trials) |
|
| APT-101 / APIE Therap (0 Trials) |
|
| aptamer-based therapeutics / GSK (0 Trials) |
|
| Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL (2 Trials) |
|
| Aptivus (tipranavir) / Boehringer Ingelheim (2 Trials) |
|
| APTO-253 / Aptose Biosci (1 Trials) |
|
| APTO-500 / Aptose Biosci (0 Trials) |
|
| ApTOLL / aptaTargets (0 Trials) |
|
| Apulmiq (liposomal ciprofloxacin DR) / Savara (0 Trials) |
|
| APVAC1 vaccine / BioNTech, Immatics (0 Trials) |
|
| APVAC2 vaccine / Immatics, BioNTech (0 Trials) |
|
| APVO-425 / Aptevo Therap (0 Trials) |
|
| APVO210 / Aptevo Therap (0 Trials) |
|
| APVO414 / Aptevo Therap (0 Trials) |
|
| APVO442 / Aptevo Therap (0 Trials) |
|
| APVO603 / Aptevo Therap (0 Trials) |
|
| APVO711 / Aptevo Therap (0 Trials) |
|
| APX-1004 / AptaBio (0 Trials) |
|
| APX-NEW / AptaBio (0 Trials) |
|
| APX002 / Mabwell (Shanghai) Biosci, Pyxis Oncology (0 Trials) |
|
| APX201 / Pyxis Oncology (0 Trials) |
|
| APX3330 / Apexian, Ocuphire Pharma (0 Trials) |
|
| APX601 / Pyxis Oncology (0 Trials) |
|
| APX701 / Pyxis Oncology (0 Trials) |
|
| APX702 / Pyxis Oncology (0 Trials) |
|
| APX801 / Pyxis Oncology (0 Trials) |
|
| APY0201 / Ajinomoto (0 Trials) |
|
| AQ280 / LEO Pharma, Aqilion (0 Trials) |
|
| AQ312 / Aqilion (0 Trials) |
|
| AQCH / Sun Pharma (0 Trials) |
|
| AQU-005 / NeuroMax, Aquilus Pharma (0 Trials) |
|
| Aquazide (hydrolchlorothiazide) / Sun Pharma (0 Trials) |
|
| Aqupla (nedaplatin) / Simcere (63 Trials) |
|
| AR-12 / Arno Therap (0 Trials) |
|
| AR-13503 / Alcon (0 Trials) |
|
| AR-15512 / Alcon (1 Trials) |
|
| AR-201 / Aridis (0 Trials) |
|
| AR-300 / Ampio (0 Trials) |
|
| AR-401 / Aridis (0 Trials) |
|
| AR-701 / Aridis (0 Trials) |
|
| AR-711 / Aridis (0 Trials) |
|
| AR-712 / Aridis (0 Trials) |
|
| AR062 / Y-Biologics (0 Trials) |
|
| AR063 / Y-Biologics (0 Trials) |
|
| AR072 / Y-Biologics, Pierre Fabre (0 Trials) |
|
| AR08 / Azurity Pharma (0 Trials) |
|
| AR081 / Y-Biologics, IntoCell (0 Trials) |
|
| AR087 / Y-Biologics, Korea Kolmar (0 Trials) |
|
| AR092 / Y-Biologics (0 Trials) |
|
| AR100 / ARJIL Pharma (0 Trials) |
|
| AR1002 / ariBio (0 Trials) |
|
| AR1003 / ariBio (0 Trials) |
|
| AR1006 / ariBio (0 Trials) |
|
| AR20 / Azurity Pharma (0 Trials) |
|
| AR201 / Nestle (0 Trials) |
|
| AR23 / Azurity Pharma (0 Trials) |
|
| AR28 / Azurity Pharma (0 Trials) |
|
| AR29 / Azurity Pharma (0 Trials) |
|
| AR30 / Azurity Pharma (0 Trials) |
|
| AR301 / Nestle (0 Trials) |
|
| AR317 / Pfizer (0 Trials) |
|
| AR401 / Nestle (0 Trials) |
|
| AR601 / Nestle (0 Trials) |
|
| AR882 / Arthrosi (0 Trials) |
|
| AR9.6 / Quest PharmaTech, OncoCare Therap (0 Trials) |
|
| AR9281 / Arete (0 Trials) |
|
| Aralast NP (alpha 1-antitrypsin) / Omni Bio Pharma, Takeda (5 Trials) |
|
| Aramchol (aramchol meglumine) / Galmed (1 Trials) |
|
| Aranesp (darbepoetin alfa) / Amgen, Kyowa Kirin (25 Trials) |
|
| arasertaconazole nitrate / Ferrer International (0 Trials) |
|
| arazasetron (SENS-401) / Sensorion (0 Trials) |
|
| Arazlo (tazarotene lotion) / Bausch Health (0 Trials) |
|
|